Condition: Cytomegalovirus (CMV) · Sponsor: Takeda
The main aim of this study is to find out the safety, tolerability and pharmacokinetics (PK) of maribavir for the treatment of CMV infection in children and teenagers after HSCT or SOT and to identify the optimal dose of maribavir using a 200 milligrams (mg) tablet formulation or powder for oral suspension. The participants will be treated with maribavir for 8 weeks. Participants need to visit their doctor during 12-week follow-up period.
This description comes directly from the study's public registry record.
Takeda Contact · +1-877-825-3327 · medinfoUS@takeda.com
Always discuss trial participation with your own doctor first.
| Nemours Children's Health - Wilmington - PIN | Wilmington, Delaware, United States | Recruiting |
| Johns Hopkins All Children's Hospital - Main - PIN | St. Petersburg, Florida, United States | Recruiting |
| Ann and Robert H Lurie Childrens Hospital of Chicago - PIN | Chicago, Illinois, United States | Recruiting |
| University of Nebraska Medical Center -985400 Nebraska Medical Center | Omaha, Nebraska, United States | Recruiting |
| Cincinnati Children's Hospital Medical Center - PIN | Cincinnati, Ohio, United States | Recruiting |
| Cook Children's Health Care System | Fort Worth, Texas, United States | Recruiting |
| University of Texas MD Anderson Cancer Center - 1515 Holcombe Blvd | Houston, Texas, United States | Recruiting |
| Texas Children's Hospital - Wallace Tower - PIN | Houston, Texas, United States | Recruiting |
| Minderoo Children's Comprehensive Cancer Centre | Randwick, New South Wales, Australia | Recruiting |
| Queensland Children's Hospital | Woollangabba, Queensland, Australia | Recruiting |
| Royal Children's Hospital Melbourne - PIN | Parkville, Victoria, Australia | Recruiting |
| Perth Children's Hospital | Nedlands, Western Australia, Australia | Recruiting |
+ 41 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05319353